Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-09

Clinical Trial Update: The Effect of N115 on Coughing in IPF Patients [Phase 3]

View source ↗

Summary

Phase 3 trial of N115 in idiopathic pulmonary fibrosis patients has completed and results have been posted. The study evaluates the effect of N115 on coughing i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N115 (N115)

Snippet

Sponsor: Cellular Sciences, inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2024-07-09